Once-Weekly Dulaglutide Is Noninferior to Daily LiraglutideOnce-Weekly Dulaglutide Is Noninferior to Daily Liraglutide

In a rare head-to-head trial of two GLP-1 receptor agonists, once-weekly dulaglutide was similar to once-daily liraglutide in efficacy and tolerability. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news